EA-3064, Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP), Faculty of Medicine of Saint-Etienne, University of Lyon, Saint-Etienne, France; Laboratory of Transmissible Diseases and Biologically Active Substances, Faculty of Pharmacy, Monastir, Tunisia.
Clin Microbiol Infect. 2014 Sep;20(9):O558-65. doi: 10.1111/1469-0691.12520. Epub 2014 Feb 8.
Typing of human enterovirus (EV) remains a major goal for diagnostic and epidemiological purposes. Whereas sequencing of the VP1 coding region is the reference standard for EV typing, a method relying on sequencing of the VP2 coding region has been proposed as an alternative; however, this has been validated only on cell culture supernatants. To avoid the selection of cultivable strains and to quicken the identification step, a new semi-nested PCR method targeting the VP2 region was developed by use of the CODEHOP strategy. After validation of the method on reference and clinical strains, a total of 352 clinical specimens found to be positive for EV RNA (138 with the GeneXpert EV kit and 214 with the Enterovirus R-gene kit) during a 3-year period (2010-2012) were analysed prospectively for VP2 genotyping. Overall, 204 (58%) specimens were typeable. A higher proportion of throat swab/stool specimens than of cerebrospinal fluid (CSF) specimens was found to be typeable (94 of 142 (66.2%) vs. 83 of 169 (49.1%), respectively, p <0.01 by the chi-square test). Moreover, the median Ct value obtained was lower for typeable specimens than for untypeable specimens (32.20 vs. 33.01, p <0.05, and 25.96 vs. 31.74, p <0.001, for the GeneXpert and R-gene tests, respectively, by the Mann-Whitney-Wilcoxon test). These results suggest that, in cases of EV meningitis, a peripheral specimen (i.e. throat swab or stool) that is susceptible to exhibiting a higher viral load should be used in preference to CSF for identifying the causative EV genotype by use of the VP2 typing method without cell culture isolation.
对人类肠道病毒 (EV) 进行分型仍然是诊断和流行病学的主要目标。虽然对 VP1 编码区进行测序是 EV 分型的参考标准,但已经提出了一种依赖于 VP2 编码区测序的替代方法;然而,这种方法仅在细胞培养上清液中得到了验证。为了避免选择可培养的菌株并加快鉴定步骤,我们使用 CODEHOP 策略开发了一种针对 VP2 区的新半巢式 PCR 方法。在对参考和临床菌株进行方法验证后,对 2010 年至 2012 年 3 年间发现的 352 份 EV RNA 阳性的临床标本(138 份使用 GeneXpert EV 试剂盒,214 份使用 Enterovirus R-gene 试剂盒)进行了前瞻性 VP2 基因分型分析。总体而言,有 204 份(58%)标本可分型。与脑脊液 (CSF) 标本相比,咽喉拭子/粪便标本的可分型比例更高(142 份中的 94 份 [66.2%] 与 169 份中的 83 份 [49.1%] 相比,chi-square 检验,p <0.01)。此外,可分型标本的中位 Ct 值低于不可分型标本(GeneXpert 和 R-gene 检测分别为 32.20 和 33.01,p <0.05 和 25.96 和 31.74,p <0.001,Mann-Whitney-Wilcoxon 检验)。这些结果表明,在 EV 脑膜炎的情况下,应使用对外周标本(即咽喉拭子或粪便)进行检测,这些标本更易于显示更高的病毒载量,而不是使用 CSF 来通过 VP2 分型方法鉴定致病 EV 基因型,而无需细胞培养分离。